malignant melanotic schwannoma Frontiers Frontiers | Case Report: Anlotinib
Frontiers Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor View of Malignant melanotic nerve sheath tumor with PRKAR1A, KMT2C and GNAQ mutations Free Neuropathology Melanotic Schwannoma Basicmedical Key Frontiers Cervical Malignant Melanotic Nerve Sheath Tumor with retained PRKAR1A expression and a clinically benign course: a case report and review of the literature Intradural Melanotic Schwannoma of the Sacral Spine: An Illustrated Case Report of Diagnostic Conundrum Post operative Stereotactic Radiosurgery of Malignant Melanotic Schwannoma Cureus
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29





